NeuroBo Pharmaceuticals Confirms Marshall Woodworth As New CFO

RTTNews | 543日前
NeuroBo Pharmaceuticals Confirms Marshall Woodworth As New CFO

(RTTNews) - Biotechnology company NeuroBo Pharmaceuticals, Inc. (NRBO) announced Monday the appointment of Marshall Woodworth as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective March 1, 2024, following his tenure as Acting Chief Financial Officer since October 27, 2023.

Marshall brings in decades of experience as a CFO for a variety of pharmaceutical and medical device companies.

Prior to joining NeuroBo, Woodworth served as the CFO at Nevakar, Inc. from May 2017 through May 2023. Prior to that, he served as the CFO of Braeburn Pharmaceuticals, Inc.

Earlier, Woodworth served as the CFO at Aerocrine AB, and, before that, held the position of CFO at Furiex Pharmaceuticals Inc.

read more
Pound Slides Against Majors

Pound Slides Against Majors

The British pound weakened against other major currencies in the European session on Friday, weighed down to a large extent by the weakness in the financial sector, amid reports of likely imposition of windfall tax on banks.
RTTNews | 1時16分前
FTSE 100 Weak Again, Looks Headed For Weekly Loss

FTSE 100 Weak Again, Looks Headed For Weekly Loss

U.K. stocks are trading lower on Friday, losing ground for a fourth straight session, weighed down to a large extent by the weakness in the financial sector, amid reports of likely imposition of windfall tax on banks.
RTTNews | 1時48分前
Pound Falls Against Majors

Pound Falls Against Majors

The British pound weakened against other major currencies in the European session on Friday.
RTTNews | 1時55分前
French Stocks Mostly Subdued In Cautious Trade

French Stocks Mostly Subdued In Cautious Trade

The French market is down in negative territory on Friday with investors digesting a slew of economic data, and look ahead to key consumer inflation report from the U.S.
RTTNews | 2時7分前